AI in Oncology Market Expansion Fueled by Advanced Imaging Genomics and Machine Learning Technologies

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Oncology Market- (Type of Cancer (Solid malignancies, Breast cancer, Lung cancer, Prostate cancer, Colorectal cancer, Brain tumor, Others), By End User (Hospitals, Pharmaceutical companies, Research Institutes, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2035."

Global AI in Oncology Market Size is valued at USD 1.91 Bn in 2025 and is predicted to reach USD 7.31 Bn by the year 2035 at an 14.5% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2529

Artificial intelligence (AI) is transforming the oncology sector by enhancing cancer diagnostics, treatment planning, and patient management through advanced machine learning algorithms and data analytics. By processing large and complex medical datasets, AI systems can identify subtle patterns and generate personalized therapeutic recommendations, supporting informed clinical decision-making and improving patient outcomes. Key technologies, including deep learning, natural language processing (NLP), computer vision, and genomics-driven analytics, play a critical role in improving diagnostic accuracy, optimizing treatment strategies, and increasing overall healthcare efficiency.

The strategic impact of AI in oncology lies in its ability to deliver precise, data-driven insights that enable accurate diagnoses and individualized care tailored to each patient's clinical profile. AI-enabled platforms also support early disease detection by analyzing patient data to identify potential health risks, facilitating proactive and preventive interventions. Furthermore, AI-driven automation enhances operational efficiency, reduces healthcare costs, and streamlines clinical workflows, positioning artificial intelligence as a transformative force within oncology and the broader healthcare ecosystem.

List of Prominent Players in the AI in Oncology Market:
• Berg
• CancerCenter.AI
• Concert AI
• GE Healthcare
• IBM Watson Health
• iCAD
• JLK Inspection
• Median Technologies
• Path AI
• Roche Diagnostics

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics of AI in Oncology
Market Drivers:
The increasing global incidence of cancer-including prevalent forms such as lung, breast, prostate, colorectal, and brain cancers-is a key factor driving the adoption of artificial intelligence (AI) technologies in oncology. According to the American Cancer Society's 2024 report, the United States is projected to record approximately 234,580 new lung cancer cases and 125,070 related deaths, highlighting the urgent need for advanced oncological solutions.

Globally, the World Health Organization (WHO) estimates nearly 20 million new cancer diagnoses annually, further emphasizing the demand for enhanced diagnostic and therapeutic interventions. AI-enabled precision medicine, which integrates complex genomic datasets, advanced medical imaging, and sophisticated analytics, plays a critical role in enabling early cancer detection, optimizing personalized treatment strategies, and improving overall patient outcomes.

Market Challenges:
Despite its potential, the broad implementation of AI in oncology faces several challenges. Limited access to high-quality, multi-institutional datasets and inconsistencies in electronic health record (EHR) data capture hinder interoperability. The lack of standardized imaging protocols and unified data-sharing frameworks further constrains clinical application, potentially affecting diagnostic accuracy and therapeutic effectiveness. Labor-intensive processes such as tumor segmentation and annotation also limit the scalability of AI solutions. Additionally, successful deployment requires effective collaboration among oncologists, radiologists, and data scientists, which can introduce operational complexities in multidisciplinary healthcare environments.

Regional Trends:
North America currently dominates the AI oncology market, supported by a well-established healthcare infrastructure, advanced medical imaging capabilities, and a strong research ecosystem. In 2024, the U.S. is expected to report approximately 2,001,140 new cancer cases and 611,720 cancer-related deaths, underscoring the critical need for innovative cancer care technologies.

The region benefits from significant R&D investments by leading academic institutions and biotechnology companies, which are driving the development of AI-powered oncology applications. Moreover, a supportive regulatory environment, including favorable reimbursement policies, facilitates the rapid adoption of AI solutions in clinical practice. Strong demand for precise, efficient diagnostic and therapeutic tools continues to reinforce North America's leadership in AI-driven oncology innovation.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2529

Recent Developments:
• In May 2024, ConcertAI launched CARA AI, its advanced predictive and generative AI suite, at the 2024 ASCO Annual Meeting, offering multi-modal data management and fostering collaborative research efforts across translational to clinical development stages. Additionally, ConcertAI introduced an update to its SmartLinQ oncology quality management platform, TriaLinQ.
• In May 2024, GE Healthcare introduces Revolution RT, its new AI-enhanced oncology solution, marking a "new era" in radiation therapy computed tomography (CT). Revolution RT features innovative hardware and software to enhance imaging accuracy and streamline simulation workflows, aiming to personalize and simplify the oncology care pathway for clinicians and patients. The technology debuted at the European Society for Therapeutic Radiology and Oncology 2024 Congress in Glasgow, Scotland.

Segmentation of AI in Oncology Market-
By Type of Cancer
• Solid malignancies
• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Brain tumor
• Others
By End User
• Hospitals
• Pharmaceutical companies
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/ai-in-oncology-market-/2529

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.